In agreement, CD36 knock-down reduced the proliferative, migratory, and invasive characteristics of breast cancer cells and reduced the expression of EMT-regulating transcription factors, as well that of EMT and stemness markers. This evidence concerns the gene CD36 and breast carcinoma.